{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T12:01:07Z","timestamp":1795089667881,"version":"4.10.2"},"reference-count":88,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,8,24]],"date-time":"2023-08-24T00:00:00Z","timestamp":1692835200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,8,24]],"date-time":"2023-08-24T00:00:00Z","timestamp":1692835200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82071395"],"award-info":[{"award-number":["82071395"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82001158"],"award-info":[{"award-number":["82001158"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100012669","name":"Natural Science Foundation Project of Chongqing, Chongqing Science and Technology Commission","doi-asserted-by":"publisher","award":["cstc2021ycjh-bgzxm0186"],"award-info":[{"award-number":["cstc2021ycjh-bgzxm0186"]}],"id":[{"id":"10.13039\/501100012669","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012669","name":"Natural Science Foundation Project of Chongqing, Chongqing Science and Technology Commission","doi-asserted-by":"publisher","award":["cstc2020jcyj-zdxmX0004"],"award-info":[{"award-number":["cstc2020jcyj-zdxmX0004"]}],"id":[{"id":"10.13039\/501100012669","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012669","name":"Natural Science Foundation Project of Chongqing, Chongqing Science and Technology Commission","doi-asserted-by":"publisher","award":["cstc2021jcyj-bsh0023"],"award-info":[{"award-number":["cstc2021jcyj-bsh0023"]}],"id":[{"id":"10.13039\/501100012669","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Science and Technology Research Program of Chongqing Municipal Education Commission","award":["KJZD-K201900403"],"award-info":[{"award-number":["KJZD-K201900403"]}]},{"name":"Innovation Research Group at Institutions of Higher Education in Chongqing","award":["CXQTP19034"],"award-info":[{"award-number":["CXQTP19034"]}]},{"name":"CQMU Program for Youth Innovation in Future Medicine","award":["W0044"],"award-info":[{"award-number":["W0044"]}]},{"name":"Graduate Student Innovation Project of Chongqing","award":["CYS17139"],"award-info":[{"award-number":["CYS17139"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The nucleotide-binding oligomeric domain (NOD)-like receptor protein 3 (NLRP3) inflammasome is believed to be a key mediator of neuroinflammation and subsequent secondary brain injury induced by ischemic stroke. However, the role and underlying mechanism of the NLRP3 inflammasome in neonates with hypoxic-ischemic encephalopathy (HIE) are still unclear.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>The protein expressions of the NLRP3 inflammasome including NLRP3, cysteinyl aspartate specific proteinase-1 (caspase-1) and interleukin-1\u03b2 (IL-1\u03b2), the \u03b1-amino-3-hydroxy-5-methyl-4-isoxazole-propionicacid receptor (AMPAR) subunit, and the ATPase valosin-containing protein (VCP\/p97), were determined by Western blotting. The interaction between p97 and AMPA glutamate receptor 1 (GluA1) was determined by co-immunoprecipitation. The histopathological level of hypoxic-ischemic brain damage (HIBD) was determined by triphenyltetrazolium chloride (TTC) staining. Polymerase chain reaction (PCR) and Western blotting were used to confirm the genotype of the knockout mice. Motor functions, including myodynamia and coordination, were evaluated by using grasping and rotarod tests. Hippocampus-dependent spatial cognitive function was measured by using the Morris-water maze (MWM).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>We reported that the NLRP3 inflammasome signaling pathway, such as NLRP3, caspase-1 and IL-1\u03b2, was activated in rats with HIBD and oxygen-glucose deprivation (OGD)-treated cultured primary neurons. Further studies showed that the protein level of the AMPAR GluA1 subunit on the hippocampal postsynaptic membrane was significantly decreased in rats with HIBD, and it could be restored to control levels after treatment with the specific caspase-1 inhibitor AC-YVAD-CMK. Similarly, in vitro studies showed that OGD reduced GluA1 protein levels on the plasma membrane in cultured primary neurons, whereas AC-YVAD-CMK treatment restored this reduction. Importantly, we showed that OGD treatment obviously enhanced the interaction between p97 and GluA1, while AC-YVAD-CMK treatment promoted the dissociation of p97 from the GluA1 complex and consequently facilitated the localization of GluA1 on the plasma membrane of cultured primary neurons. Finally, we reported that the deficits in motor function, learning and memory in animals with HIBD, were ameliorated by pharmacological intervention or genetic ablation of caspase-1.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Inhibiting the NLRP3 inflammasome signaling pathway promotes neurological recovery in animals with HIBD by increasing p97-mediated surface GluA1 expression, thereby providing new insight into HIE therapy.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12967-023-04452-5","type":"journal-article","created":{"date-parts":[[2023,8,24]],"date-time":"2023-08-24T13:02:37Z","timestamp":1692882157000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Inhibiting NLRP3 inflammasome signaling pathway promotes neurological recovery following hypoxic-ischemic brain damage by increasing p97-mediated surface GluA1-containing AMPA receptors"],"prefix":"10.1186","volume":"21","author":[{"given":"Yuxin","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yehong","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Man","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lilin","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yayan","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuyu","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu Tian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3411-7923","authenticated-orcid":false,"given":"Zhifang","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,8,24]]},"reference":[{"key":"4452_CR1","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.earlhumdev.2010.05.010","volume":"86","author":"JJ Kurinczuk","year":"2010","unstructured":"Kurinczuk JJ, White-Koning M, Badawi N. Epidemiology of neonatal encephalopathy and hypoxic-ischaemic encephalopathy. Early Hum Dev. 2010;86:329\u201338.","journal-title":"Early Hum Dev"},{"key":"4452_CR2","doi-asserted-by":"crossref","first-page":"20170861","DOI":"10.1259\/bjr.20170861","volume":"91","author":"D Sanz","year":"2018","unstructured":"Sanz D, D\u2019Arco F, Robles CA, Brierley J. Incidence and pattern of brain lesions in paediatric septic shock patients. Br J Radiol. 2018;91:20170861.","journal-title":"Br J Radiol"},{"key":"4452_CR3","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s13760-020-01308-3","volume":"120","author":"P Greco","year":"2020","unstructured":"Greco P, Nencini G, Piva I, Scioscia M, Volta CA, Spadaro S, et al. Pathophysiology of hypoxic-ischemic encephalopathy: a review of the past and a view on the future. Acta Neurol Belg. 2020;120:277\u201388.","journal-title":"Acta Neurol Belg"},{"key":"4452_CR4","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1212\/WNL.0b013e31821f442d","volume":"76","author":"M Martinez-Biarge","year":"2011","unstructured":"Martinez-Biarge M, Diez-Sebastian J, Kapellou O, Gindner D, Allsop JM, Rutherford MA, et al. Predicting motor outcome and death in term hypoxic-ischemic encephalopathy. Neurology. 2011;76:2055\u201361.","journal-title":"Neurology"},{"key":"4452_CR5","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1056\/NEJMoa1112066","volume":"366","author":"S Shankaran","year":"2012","unstructured":"Shankaran S, Pappas A, McDonald SA, Vohr BR, Hintz SR, Yolton K, et al. Childhood outcomes after hypothermia for neonatal encephalopathy. N Engl J Med. 2012;366:2085\u201392.","journal-title":"N Engl J Med"},{"key":"4452_CR6","doi-asserted-by":"crossref","DOI":"10.3390\/children5070099","volume":"5","author":"J Nair","year":"2018","unstructured":"Nair J, Kumar VHS. Current and emerging therapies in the management of hypoxic ischemic encephalopathy in neonates. Children. 2018;5: 99.","journal-title":"Children"},{"key":"4452_CR7","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/s41372-021-01022-9","volume":"41","author":"RM McAdams","year":"2021","unstructured":"McAdams RM, Berube MW. Emerging therapies and management for neonatal encephalopathy-controversies and current approaches. J Perinatol. 2021;41:661\u201374.","journal-title":"J Perinatol"},{"key":"4452_CR8","first-page":"433","volume":"24","author":"Y Liu","year":"2002","unstructured":"Liu Y, Zhu LP, He W. Toll-like receptor and innate immunity in phylogenesis. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2002;24:433\u20136.","journal-title":"Zhongguo Yi Xue Ke Xue Yuan Xue Bao"},{"key":"4452_CR9","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1002\/emmm.200900014","volume":"1","author":"SC Eisenbarth","year":"2009","unstructured":"Eisenbarth SC, Flavell RA. Innate instruction of adaptive immunity revisited: the inflammasome. EMBO Mol Med. 2009;1:92\u20138.","journal-title":"EMBO Mol Med"},{"key":"4452_CR10","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1146\/annurev.pathol.4.110807.092239","volume":"4","author":"G Chen","year":"2009","unstructured":"Chen G, Shaw MH, Kim YG, Nunez G. NOD-like receptors: role in innate immunity and inflammatory disease. Annu Rev Pathol. 2009;4:365\u201398.","journal-title":"Annu Rev Pathol"},{"key":"4452_CR11","doi-asserted-by":"crossref","first-page":"349","DOI":"10.3906\/biy-1909-31","volume":"43","author":"E Eren","year":"2019","unstructured":"Eren E, Ozoren N. The NLRP3 inflammasome: a new player in neurological diseases. Turk J Biol. 2019;43:349\u201359.","journal-title":"Turk J Biol"},{"key":"4452_CR12","doi-asserted-by":"crossref","first-page":"10086","DOI":"10.1523\/JNEUROSCI.1227-10.2010","volume":"30","author":"A Denes","year":"2010","unstructured":"Denes A, Humphreys N, Lane TE, Grencis R, Rothwell N. Chronic systemic infection exacerbates ischemic brain damage via a CCL5 (regulated on activation, normal T-cell expressed and secreted)-mediated proinflammatory response in mice. J Neurosci. 2010;30:10086\u201395.","journal-title":"J Neurosci"},{"key":"4452_CR13","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1002\/jnr.23986","volume":"95","author":"M Pennisi","year":"2017","unstructured":"Pennisi M, Crupi R, Di Paola R, Ontario ML, Bella R, Calabrese EJ, et al. Inflammasomes, hormesis, and antioxidants in neuroinflammation: role of NRLP3 in Alzheimer disease. J Neurosci Res. 2017;95:1360\u201372.","journal-title":"J Neurosci Res"},{"key":"4452_CR14","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S1097-2765(02)00599-3","volume":"10","author":"F Martinon","year":"2002","unstructured":"Martinon F, Burns K, Tschopp J. The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta. Mol Cell. 2002;10:417\u201326.","journal-title":"Mol Cell"},{"key":"4452_CR15","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1038\/nature15514","volume":"526","author":"J Shi","year":"2015","unstructured":"Shi J, Zhao Y, Wang K, Shi X, Wang Y, Huang H, et al. Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death. Nature. 2015;526:660\u20135.","journal-title":"Nature"},{"key":"4452_CR16","volume":"2016","author":"K Zhou","year":"2016","unstructured":"Zhou K, Shi L, Wang Y, Chen S, Zhang J. Recent advances of the NLRP3 inflammasome in central nervous system disorders. J Immunol Res. 2016;2016: 9238290.","journal-title":"J Immunol Res"},{"key":"4452_CR17","first-page":"63","volume":"11","author":"L Song","year":"2017","unstructured":"Song L, Pei L, Yao S, Wu Y, Shang Y. NLRP3 inflammasome in neurological diseases, from functions to therapies. Front Cell Neurosci. 2017;11:63.","journal-title":"Front Cell Neurosci"},{"key":"4452_CR18","doi-asserted-by":"crossref","first-page":"e790","DOI":"10.1038\/cddis.2013.326","volume":"4","author":"DY Fann","year":"2013","unstructured":"Fann DY, Lee SY, Manzanero S, Tang SC, Gelderblom M, Chunduri P, et al. Intravenous immunoglobulin suppresses NLRP1 and NLRP3 inflammasome-mediated neuronal death in ischemic stroke. Cell Death Dis. 2013;4:e790.","journal-title":"Cell Death Dis"},{"key":"4452_CR19","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1007\/s12035-017-0394-9","volume":"55","author":"DY Fann","year":"2018","unstructured":"Fann DY, Lim YA, Cheng YL, Lok KZ, Chunduri P, Baik SH, et al. Evidence that NF-kappaB and MAPK signaling promotes NLRP inflammasome activation in neurons following ischemic stroke. Mol Neurobiol. 2018;55:1082\u201396.","journal-title":"Mol Neurobiol"},{"key":"4452_CR20","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.1038\/s41598-019-38676-7","volume":"9","author":"YJ Chen","year":"2019","unstructured":"Chen YJ, Hsu CC, Shiao YJ, Wang HT, Lo YL, Lin AMY. Anti-inflammatory effect of afatinib (an EGFR-TKI) on OGD-induced neuroinflammation. Sci Rep. 2019;9:2516.","journal-title":"Sci Rep"},{"key":"4452_CR21","doi-asserted-by":"crossref","DOI":"10.1083\/jcb.202103052","volume":"220","author":"TC Sudhof","year":"2021","unstructured":"Sudhof TC. The cell biology of synapse formation. J Cell Biol. 2021;220: e202103052.","journal-title":"J Cell Biol"},{"key":"4452_CR22","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1124\/pr.109.002451","volume":"62","author":"SF Traynelis","year":"2010","unstructured":"Traynelis SF, Wollmuth LP, McBain CJ, Menniti FS, Vance KM, Ogden KK, et al. Glutamate receptor ion channels: structure, regulation, and function. Pharmacol Rev. 2010;62:405\u201396.","journal-title":"Pharmacol Rev"},{"key":"4452_CR23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neuropharm.2013.05.009","volume":"74","author":"BG Frenguelli","year":"2013","unstructured":"Frenguelli BG. Glutamate receptor-dependent synaptic plasticity. Neuropharmacology. 2013;74:1.","journal-title":"Neuropharmacology"},{"key":"4452_CR24","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1146\/annurev.ne.13.030190.001131","volume":"13","author":"DW Choi","year":"1990","unstructured":"Choi DW, Rothman SM. The role of glutamate neurotoxicity in hypoxic-ischemic neuronal death. Annu Rev Neurosci. 1990;13:171\u201382.","journal-title":"Annu Rev Neurosci"},{"key":"4452_CR25","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1001\/jamapediatrics.2014.3269","volume":"169","author":"M Douglas-Escobar","year":"2015","unstructured":"Douglas-Escobar M, Weiss MD. Hypoxic-ischemic encephalopathy: a review for the clinician. JAMA Pediatr. 2015;169:397\u2013403.","journal-title":"JAMA Pediatr"},{"key":"4452_CR26","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1161\/01.STR.0000047101.87575.3C","volume":"34","author":"C Manabat","year":"2003","unstructured":"Manabat C, Han BH, Wendland M, Derugin N, Fox CK, Choi J, et al. Reperfusion differentially induces caspase-3 activation in ischemic core and penumbra after stroke in immature brain. Stroke. 2003;34:207\u201313.","journal-title":"Stroke"},{"key":"4452_CR27","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1056\/NEJM199403033300907","volume":"330","author":"SA Lipton","year":"1994","unstructured":"Lipton SA, Rosenberg PA. Excitatory amino acids as a final common pathway for neurologic disorders. N Engl J Med. 1994;330:613\u201322.","journal-title":"N Engl J Med"},{"key":"4452_CR28","doi-asserted-by":"crossref","first-page":"40","DOI":"10.3389\/fnins.2014.00040","volume":"8","author":"G Wassink","year":"2014","unstructured":"Wassink G, Gunn ER, Drury PP, Bennet L, Gunn AJ. The mechanisms and treatment of asphyxial encephalopathy. Front Neurosci. 2014;8:40.","journal-title":"Front Neurosci"},{"key":"4452_CR29","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1212\/WNL.39.5.713","volume":"39","author":"H Hattori","year":"1989","unstructured":"Hattori H, Morin AM, Schwartz PH, Fujikawa DG, Wasterlain CG. Posthypoxic treatment with MK-801 reduces hypoxic-ischemic damage in the neonatal rat. Neurology. 1989;39:713\u20138.","journal-title":"Neurology"},{"key":"4452_CR30","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1161\/01.STR.23.1.82","volume":"23","author":"K Hewitt","year":"1992","unstructured":"Hewitt K, Corbett D. Combined treatment with MK-801 and nicardipine reduces global ischemic damage in the gerbil. Stroke. 1992;23:82\u20136.","journal-title":"Stroke"},{"key":"4452_CR31","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0920-1211(96)00904-7","volume":"26","author":"CE Stafstrom","year":"1997","unstructured":"Stafstrom CE, Tandon P, Hori A, Liu Z, Mikati MA, Holmes GL. Acute effects of MK801 on kainic acid-induced seizures in neonatal rats. Epilepsy Res. 1997;26:335\u201344.","journal-title":"Epilepsy Res"},{"key":"4452_CR32","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1038\/330604a0","volume":"330","author":"G Collingridge","year":"1987","unstructured":"Collingridge G. Synaptic plasticity. The role of NMDA receptors in learning and memory. Nature. 1987;330:604\u20135.","journal-title":"Nature"},{"key":"4452_CR33","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1161\/01.STR.0000025518.34157.51","volume":"33","author":"DJ Gladstone","year":"2002","unstructured":"Gladstone DJ, Black SE, Hakim AM, Heart and Stroke Foundation of Ontario Centre of Excellence in Stroke R. Toward wisdom from failure: lessons from neuroprotective stroke trials and new therapeutic directions. Stroke. 2002;33:2123\u201336.","journal-title":"Stroke"},{"key":"4452_CR34","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S1474-4422(02)00164-3","volume":"1","author":"C Ikonomidou","year":"2002","unstructured":"Ikonomidou C, Turski L. Why did NMDA receptor antagonists fail clinical trials for stroke and traumatic brain injury? Lancet Neurol. 2002;1:383\u20136.","journal-title":"Lancet Neurol"},{"key":"4452_CR35","doi-asserted-by":"crossref","first-page":"828","DOI":"10.3892\/br.2013.154","volume":"1","author":"XJ Tang","year":"2013","unstructured":"Tang XJ, Xing F. Calcium-permeable AMPA receptors in neonatal hypoxic-ischemic encephalopathy (Review). Biomed Rep. 2013;1:828\u201332.","journal-title":"Biomed Rep"},{"key":"4452_CR36","doi-asserted-by":"publisher","DOI":"10.1523\/ENEURO.0116-17.2017","author":"S Haj-Dahmane","year":"2017","unstructured":"Haj-Dahmane S, Beique JC, Shen RY. GluA2-lacking AMPA receptors and nitric oxide signaling gate spike-timing-dependent potentiation of glutamate synapses in the dorsal raphe nucleus. eNeuro. 2017. https:\/\/doi.org\/10.1523\/ENEURO.0116-17.2017.","journal-title":"eNeuro"},{"key":"4452_CR37","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/mp.2017.76","volume":"23","author":"MX Li","year":"2018","unstructured":"Li MX, Zheng HL, Luo Y, He JG, Wang W, Han J, et al. Gene deficiency and pharmacological inhibition of caspase-1 confers resilience to chronic social defeat stress via regulating the stability of surface AMPARs. Mol Psychiatry. 2018;23:556\u201368.","journal-title":"Mol Psychiatry"},{"key":"4452_CR38","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1515\/revneuro-2016-0022","volume":"28","author":"L Huang","year":"2017","unstructured":"Huang L, Zhao F, Qu Y, Zhang L, Wang Y, Mu D. Animal models of hypoxic-ischemic encephalopathy: optimal choices for the best outcomes. Rev Neurosci. 2017;28:31\u201343.","journal-title":"Rev Neurosci"},{"key":"4452_CR39","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1038\/s41418-021-00757-4","volume":"28","author":"C Dai","year":"2021","unstructured":"Dai C, Wu B, Chen Y, Li X, Bai Y, Du Y, et al. Aagab acts as a novel regulator of NEDD4-1-mediated Pten nuclear translocation to promote neurological recovery following hypoxic-ischemic brain damage. Cell Death Differ. 2021;28:2367\u201384.","journal-title":"Cell Death Differ"},{"key":"4452_CR40","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1002\/ana.410090206","volume":"9","author":"JE Rice III","year":"1981","unstructured":"Rice JE III, Vannucci RC, Brierley JB. The influence of immaturity on hypoxic-ischemic brain damage in the rat. Ann Neurol. 1981;9:131\u201341.","journal-title":"Ann Neurol"},{"key":"4452_CR41","volume":"14","author":"Y Min","year":"2020","unstructured":"Min Y, Yan L, Wang Q, Wang F, Hua H, Yuan Y, et al. Distinct residential and infiltrated macrophage populations and their phagocytic function in mild and severe neonatal hypoxic-ischemic brain damage. Front Cell Neurosci. 2020;14: 244.","journal-title":"Front Cell Neurosci"},{"key":"4452_CR42","doi-asserted-by":"crossref","first-page":"7997","DOI":"10.1523\/JNEUROSCI.5661-12.2013","volume":"33","author":"S Zhang","year":"2013","unstructured":"Zhang S, Taghibiglou C, Girling K, Dong Z, Lin SZ, Lee W, et al. Critical role of increased PTEN nuclear translocation in excitotoxic and ischemic neuronal injuries. J Neurosci. 2013;33:7997\u20138008.","journal-title":"J Neurosci"},{"key":"4452_CR43","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.neuropharm.2018.01.030","volume":"133","author":"Y Yu","year":"2018","unstructured":"Yu Y, Huang Z, Dai C, Du Y, Han H, Wang YT, et al. Facilitated AMPAR endocytosis causally contributes to the maternal sleep deprivation-induced impairments of synaptic plasticity and cognition in the offspring rats. Neuropharmacology. 2018;133:155\u201362.","journal-title":"Neuropharmacology"},{"key":"4452_CR44","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1172\/JCI77888","volume":"125","author":"Z Dong","year":"2015","unstructured":"Dong Z, Han H, Li H, Bai Y, Wang W, Tu M, et al. Long-term potentiation decay and memory loss are mediated by AMPAR endocytosis. J Clin Invest. 2015;125:234\u201347.","journal-title":"J Clin Invest"},{"key":"4452_CR45","doi-asserted-by":"crossref","first-page":"4089","DOI":"10.1038\/s41467-019-12096-7","volume":"10","author":"Y Ge","year":"2019","unstructured":"Ge Y, Tian M, Liu L, Wong TP, Gong B, Wu D, et al. p97 regulates GluA1 homomeric AMPA receptor formation and plasma membrane expression. Nat Commun. 2019;10:4089.","journal-title":"Nat Commun"},{"key":"4452_CR46","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.neuron.2018.10.018","volume":"100","author":"GH Diering","year":"2018","unstructured":"Diering GH, Huganir RL. The AMPA receptor code of synaptic plasticity. Neuron. 2018;100:314\u201329.","journal-title":"Neuron"},{"key":"4452_CR47","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1177\/08830738010160110201","volume":"16","author":"ME Dilenge","year":"2001","unstructured":"Dilenge ME, Majnemer A, Shevell MI. Long-term developmental outcome of asphyxiated term neonates. J Child Neurol. 2001;16:781\u201392.","journal-title":"J Child Neurol"},{"key":"4452_CR48","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1111\/j.1467-7687.2006.00498.x","volume":"9","author":"H Golan","year":"2006","unstructured":"Golan H, Huleihel M. The effect of prenatal hypoxia on brain development: short- and long-term consequences demonstrated in rodent models. Dev Sci. 2006;9:338\u201349.","journal-title":"Dev Sci"},{"key":"4452_CR49","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1212\/WNL.59.6.824","volume":"59","author":"RC McKinstry","year":"2002","unstructured":"McKinstry RC, Miller JH, Snyder AZ, Mathur A, Schefft GL, Almli CR, et al. A prospective, longitudinal diffusion tensor imaging study of brain injury in newborns. Neurology. 2002;59:824\u201333.","journal-title":"Neurology"},{"key":"4452_CR50","first-page":"57","volume":"18","author":"SM Rothman","year":"1995","unstructured":"Rothman SM, Olney JW. Excitotoxicity and the NMDA receptor\u2013still lethal after eight years. Trends Neurosci. 1995;18:57\u20138.","journal-title":"Trends Neurosci"},{"key":"4452_CR51","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1097\/WCO.0b013e3282f4958b","volume":"21","author":"KB Nelson","year":"2008","unstructured":"Nelson KB, Chang T. Is cerebral palsy preventable? Curr Opin Neurol. 2008;21:129\u201335.","journal-title":"Curr Opin Neurol"},{"key":"4452_CR52","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1016\/0002-9378(91)91440-8","volume":"164","author":"MI Espinoza","year":"1991","unstructured":"Espinoza MI, Parer JT. Mechanisms of asphyxial brain damage, and possible pharmacologic interventions, in the fetus. Am J Obstet Gynecol. 1991;164:1582\u20139 (discussion 1589\u201391).","journal-title":"Am J Obstet Gynecol"},{"key":"4452_CR53","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1080\/14737175.2017.1259567","volume":"17","author":"EP Yildiz","year":"2017","unstructured":"Yildiz EP, Ekici B, Tatli B. Neonatal hypoxic ischemic encephalopathy: an update on disease pathogenesis and treatment. Expert Rev Neurother. 2017;17:449\u201359.","journal-title":"Expert Rev Neurother"},{"key":"4452_CR54","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1177\/0963689718766362","volume":"27","author":"A Al Mamun","year":"2018","unstructured":"Al Mamun A, Yu H, Romana S, Liu F. Inflammatory responses are sex specific in chronic hypoxic-ischemic encephalopathy. Cell Transpl. 2018;27:1328\u201339.","journal-title":"Cell Transpl"},{"key":"4452_CR55","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1038\/aps.2013.89","volume":"34","author":"F Liu","year":"2013","unstructured":"Liu F, McCullough LD. Inflammatory responses in hypoxic ischemic encephalopathy. Acta Pharmacol Sin. 2013;34:1121\u201330.","journal-title":"Acta Pharmacol Sin"},{"key":"4452_CR56","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1742-2094-10-13","volume":"10","author":"RK Jellema","year":"2013","unstructured":"Jellema RK, Lima Passos V, Zwanenburg A, Ophelders DR, De Munter S, Vanderlocht J, et al. Cerebral inflammation and mobilization of the peripheral immune system following global hypoxia-ischemia in preterm sheep. J Neuroinflamm. 2013;10:13.","journal-title":"J Neuroinflamm"},{"key":"4452_CR57","volume":"2021","author":"JJ Zhu","year":"2021","unstructured":"Zhu JJ, Yu BY, Huang XK, He MZ, Chen BW, Chen TT, et al. Neferine protects against hypoxic-ischemic brain damage in neonatal rats by suppressing NLRP3-mediated inflammasome activation. Oxid Med Cell Longev. 2021;2021: 6654954.","journal-title":"Oxid Med Cell Longev"},{"key":"4452_CR58","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1006\/exnr.1994.1215","volume":"130","author":"D Martin","year":"1994","unstructured":"Martin D, Chinookoswong N, Miller G. The interleukin-1 receptor antagonist (rhIL-1ra) protects against cerebral infarction in a rat model of hypoxia-ischemia. Exp Neurol. 1994;130:362\u20137.","journal-title":"Exp Neurol"},{"key":"4452_CR59","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1128\/MCB.00775-14","volume":"35","author":"JA Segovia","year":"2015","unstructured":"Segovia JA, Tsai SY, Chang TH, Shil NK, Weintraub ST, Short JD, et al. Nedd8 regulates inflammasome-dependent caspase-1 activation. Mol Cell Biol. 2015;35:582\u201397.","journal-title":"Mol Cell Biol"},{"key":"4452_CR60","volume":"6","author":"F Zhang","year":"2016","unstructured":"Zhang F, Wang L, Wang JJ, Luo PF, Wang XT, Xia ZF. The caspase-1 inhibitor AC-YVAD-CMK attenuates acute gastric injury in mice: involvement of silencing NLRP3 inflammasome activities. Sci Rep. 2016;6: 24166.","journal-title":"Sci Rep"},{"key":"4452_CR61","doi-asserted-by":"crossref","first-page":"E6065","DOI":"10.1073\/pnas.1722041115","volume":"115","author":"BA McKenzie","year":"2018","unstructured":"McKenzie BA, Mamik MK, Saito LB, Boghozian R, Monaco MC, Major EO, et al. Caspase-1 inhibition prevents glial inflammasome activation and pyroptosis in models of multiple sclerosis. Proc Natl Acad Sci USA. 2018;115:E6065\u201374.","journal-title":"Proc Natl Acad Sci USA"},{"key":"4452_CR62","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1172\/JCI119153","volume":"99","author":"AJ Gunn","year":"1997","unstructured":"Gunn AJ, Gunn TR, de Haan HH, Williams CE, Gluckman PD. Dramatic neuronal rescue with prolonged selective head cooling after ischemia in fetal lambs. J Clin Invest. 1997;99:248\u201356.","journal-title":"J Clin Invest"},{"key":"4452_CR63","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/s12974-019-1505-5","volume":"16","author":"L Todd","year":"2019","unstructured":"Todd L, Palazzo I, Suarez L, Liu X, Volkov L, Hoang TV, et al. Reactive microglia and IL1beta\/IL-1R1-signaling mediate neuroprotection in excitotoxin-damaged mouse retina. J Neuroinflamm. 2019;16:118.","journal-title":"J Neuroinflamm"},{"key":"4452_CR64","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.tins.2021.01.001","volume":"44","author":"N Plotegher","year":"2021","unstructured":"Plotegher N, Filadi R, Pizzo P, Duchen MR. Excitotoxicity revisited: mitochondria on the verge of a nervous breakdown. Trends Neurosci. 2021;44:342\u201351.","journal-title":"Trends Neurosci"},{"key":"4452_CR65","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1097\/01.WCB.0000133250.03953.63","volume":"24","author":"RC Vannucci","year":"2004","unstructured":"Vannucci RC, Towfighi J, Vannucci SJ. Secondary energy failure after cerebral hypoxia-ischemia in the immature rat. J Cereb Blood Flow Metab. 2004;24:1090\u20137.","journal-title":"J Cereb Blood Flow Metab"},{"key":"4452_CR66","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1600-0404.1989.tb01779.x","volume":"126","author":"B Halliwell","year":"1989","unstructured":"Halliwell B. Oxidants and the central nervous system: some fundamental questions. Is oxidant damage relevant to Parkinson\u2019s disease, Alzheimer\u2019s disease, traumatic injury or stroke? Acta Neurol Scand Suppl. 1989;126:23\u201333.","journal-title":"Acta Neurol Scand Suppl"},{"key":"4452_CR67","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1111\/j.1471-4159.1992.tb10990.x","volume":"59","author":"B Halliwell","year":"1992","unstructured":"Halliwell B. Reactive oxygen species and the central nervous system. J Neurochem. 1992;59:1609\u201323.","journal-title":"J Neurochem"},{"key":"4452_CR68","doi-asserted-by":"crossref","first-page":"8154","DOI":"10.1523\/JNEUROSCI.21-20-08154.2001","volume":"21","author":"RM Sanchez","year":"2001","unstructured":"Sanchez RM, Koh S, Rio C, Wang C, Lamperti ED, Sharma D, et al. Decreased glutamate receptor 2 expression and enhanced epileptogenesis in immature rat hippocampus after perinatal hypoxia-induced seizures. J Neurosci. 2001;21:8154\u201363.","journal-title":"J Neurosci"},{"key":"4452_CR69","doi-asserted-by":"crossref","first-page":"5309","DOI":"10.1523\/JNEUROSCI.0567-06.2006","volume":"26","author":"B Liu","year":"2006","unstructured":"Liu B, Liao M, Mielke JG, Ning K, Chen Y, Li L, et al. Ischemic insults direct glutamate receptor subunit 2-lacking AMPA receptors to synaptic sites. J Neurosci. 2006;26:5309\u201319.","journal-title":"J Neurosci"},{"key":"4452_CR70","first-page":"636","volume":"13","author":"LM Achzet","year":"2021","unstructured":"Achzet LM, Astruc-Diaz F, Beske PH, Natale NR, Denton TT, Jackson DA. Liposomal encapsulated FSC231, a PICK1 inhibitor, prevents the ischemia\/reperfusion-induced degradation of GluA2-containing. AMPA Recept Pharm. 2021;13:636.","journal-title":"AMPA Recept Pharm"},{"key":"4452_CR71","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nrn.2016.37","volume":"17","author":"JM Henley","year":"2016","unstructured":"Henley JM, Wilkinson KA. Synaptic AMPA receptor composition in development, plasticity and disease. Nat Rev Neurosci. 2016;17:337\u201350.","journal-title":"Nat Rev Neurosci"},{"key":"4452_CR72","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.neuron.2009.02.027","volume":"62","author":"W Lu","year":"2009","unstructured":"Lu W, Shi Y, Jackson AC, Bjorgan K, During MJ, Sprengel R, et al. Subunit composition of synaptic AMPA receptors revealed by a single-cell genetic approach. Neuron. 2009;62:254\u201368.","journal-title":"Neuron"},{"key":"4452_CR73","volume":"10","author":"S Jurado","year":"2017","unstructured":"Jurado S. AMPA receptor trafficking in natural and pathological aging. Front Mol Neurosci. 2017;10: 446.","journal-title":"Front Mol Neurosci"},{"key":"4452_CR74","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1002\/1096-9861(20001106)427:1<109::AID-CNE7>3.0.CO;2-T","volume":"427","author":"JE Turman Jr","year":"2000","unstructured":"Turman JE Jr, MacDonald AS, Pawl KE, Bringas P, Chandler SH. AMPA receptor subunit expression in trigeminal neurons during postnatal development. J Comp Neurol. 2000;427:109\u201323.","journal-title":"J Comp Neurol"},{"key":"4452_CR75","volume":"9","author":"J Fernandes","year":"2014","unstructured":"Fernandes J, Vieira M, Carreto L, Santos MA, Duarte CB, Carvalho AL, et al. In vitro ischemia triggers a transcriptional response to down-regulate synaptic proteins in hippocampal neurons. PLoS ONE. 2014;9: e99958.","journal-title":"PLoS ONE"},{"key":"4452_CR76","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1111\/jnc.13005","volume":"132","author":"PH Beske","year":"2015","unstructured":"Beske PH, Byrnes NM, Astruc-Diaz F, Jackson DA. Identification of NADPH oxidase as a key mediator in the post-ischemia-induced sequestration and degradation of the GluA2 AMPA receptor subunit. J Neurochem. 2015;132:504\u201319.","journal-title":"J Neurochem"},{"key":"4452_CR77","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2018.00022","volume":"12","author":"EV Jones","year":"2018","unstructured":"Jones EV, Bernardinelli Y, Zarruk JG, Chierzi S, Murai KK. SPARC and GluA1-containing AMPA receptors promote neuronal health following CNS injury. Front Cell Neurosci. 2018;12: 22.","journal-title":"Front Cell Neurosci"},{"key":"4452_CR78","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22020717","volume":"22","author":"LM Achzet","year":"2021","unstructured":"Achzet LM, Davison CJ, Shea M, Sturgeon I, Jackson DA. Oxidative stress underlies the ischemia\/reperfusion-induced internalization and degradation of AMPA receptors. Int J Mol Sci. 2021;22: 717.","journal-title":"Int J Mol Sci"},{"key":"4452_CR79","doi-asserted-by":"crossref","first-page":"4644","DOI":"10.1074\/jbc.M113.533182","volume":"289","author":"E Blanco-Suarez","year":"2014","unstructured":"Blanco-Suarez E, Hanley JG. Distinct subunit-specific alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor trafficking mechanisms in cultured cortical and hippocampal neurons in response to oxygen and glucose deprivation. J Biol Chem. 2014;289:4644\u201351.","journal-title":"J Biol Chem"},{"key":"4452_CR80","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2020.104848","volume":"140","author":"P Mazzocchetti","year":"2020","unstructured":"Mazzocchetti P, Mancini A, Sciaccaluga M, Megaro A, Bellingacci L, Di Filippo M, et al. Low doses of perampanel protect striatal and hippocampal neurons against in vitro ischemia by reversing the ischemia-induced alteration of AMPA receptor subunit composition. Neurobiol Dis. 2020;140: 104848.","journal-title":"Neurobiol Dis"},{"key":"4452_CR81","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.nbd.2014.05.023","volume":"70","author":"E Gerace","year":"2014","unstructured":"Gerace E, Masi A, Resta F, Felici R, Landucci E, Mello T, et al. PARP-1 activation causes neuronal death in the hippocampal CA1 region by increasing the expression of Ca(2+)-permeable AMPA receptors. Neurobiol Dis. 2014;70:43\u201352.","journal-title":"Neurobiol Dis"},{"key":"4452_CR82","doi-asserted-by":"crossref","first-page":"14230","DOI":"10.1074\/jbc.M901203200","volume":"284","author":"RM Dixon","year":"2009","unstructured":"Dixon RM, Mellor JR, Hanley JG. PICK1-mediated glutamate receptor subunit 2 (GluR2) trafficking contributes to cell death in oxygen\/glucose-deprived hippocampal neurons. J Biol Chem. 2009;284:14230\u20135.","journal-title":"J Biol Chem"},{"key":"4452_CR83","volume":"2012","author":"G Wang","year":"2012","unstructured":"Wang G, Gilbert J, Man HY. AMPA receptor trafficking in homeostatic synaptic plasticity: functional molecules and signaling cascades. Neural Plast. 2012;2012: 825364.","journal-title":"Neural Plast"},{"key":"4452_CR84","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1523\/JNEUROSCI.0735-14.2015","volume":"35","author":"J Lopez","year":"2015","unstructured":"Lopez J, Gamache K, Schneider R, Nader K. Memory retrieval requires ongoing protein synthesis and NMDA receptor activity-mediated AMPA receptor trafficking. J Neurosci. 2015;35:2465\u201375.","journal-title":"J Neurosci"},{"key":"4452_CR85","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.neuropharm.2018.11.022","volume":"146","author":"JM Li","year":"2019","unstructured":"Li JM, Liu LL, Su WJ, Wang B, Zhang T, Zhang Y, et al. Ketamine may exert antidepressant effects via suppressing NLRP3 inflammasome to upregulate AMPA receptors. Neuropharmacology. 2019;146:149\u201353.","journal-title":"Neuropharmacology"},{"key":"4452_CR86","first-page":"3877","volume":"127","author":"H Meyer","year":"2014","unstructured":"Meyer H, Weihl CC. The VCP\/p97 system at a glance: connecting cellular function to disease pathogenesis. J Cell Sci. 2014;127:3877\u201383.","journal-title":"J Cell Sci"},{"key":"4452_CR87","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.molcel.2017.10.028","volume":"69","author":"J van den Boom","year":"2018","unstructured":"van den Boom J, Meyer H. VCP\/p97-mediated unfolding as a principle in protein homeostasis and signaling. Mol Cell. 2018;69:182\u201394.","journal-title":"Mol Cell"},{"key":"4452_CR88","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1111\/j.1582-4934.2008.00462.x","volume":"12","author":"N Vij","year":"2008","unstructured":"Vij N. AAA ATPase p97\/VCP: cellular functions, disease and therapeutic potential. J Cell Mol Med. 2008;12:2511\u20138.","journal-title":"J Cell Mol Med"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-023-04452-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-023-04452-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-023-04452-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,18]],"date-time":"2023-11-18T15:26:27Z","timestamp":1700321187000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-023-04452-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,24]]},"references-count":88,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["4452"],"URL":"https:\/\/doi.org\/10.1186\/s12967-023-04452-5","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,24]]},"assertion":[{"value":"22 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All the animal research were performed in accordance with the Chongqing Science and Technology Commission guidelines and approved by the Animal Ethics Committee of Children\u2019s Hospital of Chongqing Medical University (No. CHCMU-IACUC20210114017).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"567"}}